Business Wire05.24.18
Spectrum Plastics Group, the medical extruder with complementary injection molding, silicone, and assembly capabilities, is pleased to announce the acquisition of Fermatex Vascular Technologies Inc., formerly Gore-Jersey Shore and most notably Adam Spence Corporation, from Vance Street Capital LLC. Fermatex is a supplier of reinforced medical tubing, catheter subassemblies, and specialty extrusions.
As an operation Fermatex is best known by its heritage and lineage as Adam Spence Corporation, which was founded in 1960. The business was later acquired by WL Gore in 2004 and recently sold to Vance Street Capital in 2017. It has been supporting the medical device industry for over 50 years and today employs approximately 100 people out of two adjoining ISO 13485 certified buildings encompassing 54,000 sq. feet, including certified clean rooms, in Wall, New Jersey. Spectrum Plastics Group intends to support the transition of the Fermatex brand back to Adam Spence, given the wider familiarity of its history and reputation.
Neil Shillingford, Spectrum Plastics CEO, remarked, "We are happy to welcome the Adam Spence team to the Spectrum Plastics Group. Its heritage and skills suit both our culture and objectives as leading medical device component and contract manufacturers. Combined, during this era of industry transition, our operations present exceptional scale and capability to medical device OEMs seeking the proper manufacturing partner for highly specialized components, catheter delivery systems and sub-assemblies.” The Adam Spence facilities will ultimately operate under Spectrum Plastics’ specialty technologies platform and work in tandem with its Apollo Medical Extrusion Technologies units and brand.
Mike Janish, CEO of Fermatex, will assist in transitioning the Jersey Shore operation. He remarks, “This is a great fit for Fermatex and to align ourselves with the global reach and resources of Spectrum Plastics Group. Spectrum Plastics is a natural extension for the ambitions we’ve had here since we started last year and we look forward to embedding ourselves with their team.”
Spectrum Plastics Group has executed 8 acquisitions during the last four years as it has evolved into a comprehensive medical components and plastics manufacturer. This event marks its second acquisition in the last three months, having acquired the precision injection molder Apex Resource Technologies in February of this year.
Both Spectrum Plastics Group and Fermatex will be exhibiting at the MD&M East show in New York City the second week of June, booths #1232 and #1638 respectively. Fermatex will be exhibiting as Adam Spence Vascular Technologies.
As an operation Fermatex is best known by its heritage and lineage as Adam Spence Corporation, which was founded in 1960. The business was later acquired by WL Gore in 2004 and recently sold to Vance Street Capital in 2017. It has been supporting the medical device industry for over 50 years and today employs approximately 100 people out of two adjoining ISO 13485 certified buildings encompassing 54,000 sq. feet, including certified clean rooms, in Wall, New Jersey. Spectrum Plastics Group intends to support the transition of the Fermatex brand back to Adam Spence, given the wider familiarity of its history and reputation.
Neil Shillingford, Spectrum Plastics CEO, remarked, "We are happy to welcome the Adam Spence team to the Spectrum Plastics Group. Its heritage and skills suit both our culture and objectives as leading medical device component and contract manufacturers. Combined, during this era of industry transition, our operations present exceptional scale and capability to medical device OEMs seeking the proper manufacturing partner for highly specialized components, catheter delivery systems and sub-assemblies.” The Adam Spence facilities will ultimately operate under Spectrum Plastics’ specialty technologies platform and work in tandem with its Apollo Medical Extrusion Technologies units and brand.
Mike Janish, CEO of Fermatex, will assist in transitioning the Jersey Shore operation. He remarks, “This is a great fit for Fermatex and to align ourselves with the global reach and resources of Spectrum Plastics Group. Spectrum Plastics is a natural extension for the ambitions we’ve had here since we started last year and we look forward to embedding ourselves with their team.”
Spectrum Plastics Group has executed 8 acquisitions during the last four years as it has evolved into a comprehensive medical components and plastics manufacturer. This event marks its second acquisition in the last three months, having acquired the precision injection molder Apex Resource Technologies in February of this year.
Both Spectrum Plastics Group and Fermatex will be exhibiting at the MD&M East show in New York City the second week of June, booths #1232 and #1638 respectively. Fermatex will be exhibiting as Adam Spence Vascular Technologies.
